Day: August 7, 2024

Hamilton Thorne to Release Q2 2024 Financial Results on August 14, 2024

BEVERLY, Mass. and TORONTO, Aug. 07, 2024 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and six months ended June 30, 2024 before market open on Wednesday, August 14, 2024. The press release, with accompanying financial information, will be posted on the Company’s website at www.hamiltonthorne.ltd and on www.sedarplus.ca. The Company’s updated investor presentation will be available on Hamilton Thorne’s website shortly after the release. The Company announced it will not be hosting a conference call. About Hamilton Thorne Ltd. (www.hamiltonthorne.ltd) Hamilton Thorne...

Continue reading

Gaxos to Participate in Upcoming Devcom and Gamescom Conferences on August 18th to 25th in Cologne, Germany

Roseland, NJ, Aug. 07, 2024 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Devcom Developer Conference on August 18th – Aug 20th and Gamescom Conference on August 21st – 25th in Cologne, Germany. “We are excited to be part of Devcom and Gamescom this year,” said Vadim Mats, CEO of Gaxos. “These conferences provide us with a fantastic opportunity to engage with developers, industry leaders, and gamers. We expect to forge meaningful relationships and connections that will help grow our AI product for game developers and publishers.” To meet with Gaxos at the conferences or for press inquiries, please email press@gaxos.ai About Devcom Developer Conference...

Continue reading

CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024

BERKELEY HEIGHTS, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it will report its financial results for the second quarter ended June 30, 2024, before the market opens on Wednesday, August 14, 2024, and will host a corporate update conference call at 8:30am Eastern Time. Wednesday, August 14th @ 8:30am ET Domestic: 1-877-270-2148 International: 1-412-902-6510 Webcast: Webcast Link About CorMedixCorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath®,...

Continue reading

HeartCore to Present at the 2024 Gateway Conference on September 4 at 10:30 a.m. Pacific Time

NEW YORK and TOKYO, Aug. 07, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and data consulting services company based in Tokyo, is confirmed to present at the 2024 Annual Gateway Conference, which is being held September 4-5, at the Four Seasons Hotel in San Francisco, CA. HeartCore’s management team is scheduled to present on Wednesday, September 4 at 10:30 a.m. Pacific Time (PT). The presentation will be webcast live and available for replay here. In addition to the presentation, HeartCore’s executives will be available for one-on-one meetings throughout the conference. For additional information, to request an invitation, or to schedule a one-on-one meeting, please email conference@gateway-grp.com. About The Gateway ConferenceSet against...

Continue reading

Image Protect, Inc. (OTC:IMTL) Adds New MMS Text Marketing Program Allowing Images and Video to be Embedded in Text Messaging Via Its Popular 2CentTexts Platform

NEW YORK, NY, Aug. 07, 2024 (GLOBE NEWSWIRE) — Image Protect, Inc. (OTC:IMTL) (Imageprotectcorporation.com) (“Image Protect” or the “Company”), through its subsidiary Review Control™ Reputation Management, a leading player in the digital content protection arena, is pleased to announce the addition of its new MMS Text Marketing service, offering the most cutting-edge technology for its clients. The company’s new MMS (Multi-Media Messaging Service) Text Marketing feature will now give clients the ability to send both images and video inside their outbound text messaging, making it exponentially more powerful and gaining even greater ROI on their spending with 2CentTexts. The company is pleased to announce the completion and launch of its new website, MMS Text Marketing Program, and Loyalty Club Program for all sized businesses...

Continue reading

Trust Stamp has licensed its computer vision and other AI-based technologies for use in Hydrogen-Powered Search & Rescue, Humanitarian Services, Surveillance, and Delivery Drones in a transaction generating $5,000,000 of income for Trust Stamp in Q3 of 2024

ATLANTA, Aug. 07, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), a global provider of AI-powered technologies, announces a strategic implementation with Boumarang Inc. (“Boumarang”), a pioneer in drone technology and hydrogen power solutions. The implementation will see Trust Stamp’s computer vision, data tokenization, and other AI-powered technologies integrated into and used in conjunction with groundbreaking hydrogen-powered UAV systems. Market Opportunity: The global drone market was valued at USD 22.4 billion in 2022, and it is expected to grow from USD 28 billion in 2023 to USD 166.7 billion by 2031, with a compound annual growth rate (CAGR) of 25% during the forecast period from 2024 to 2031. The collaboration between Trust Stamp and Boumarang addresses a burgeoning market opportunity as businesses and governments worldwide...

Continue reading

SKYX Announces Corporate Update Call

Company to Provide Corporate Updates Including Second Quarter 2024 Financial Results; Conference Call to be Held on Monday, August 12, 2024 at 4:30 PM Eastern Time MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) — SKYX (NASDAQ: SKYX) (d/b/a “SKYX Technologies”), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home décor websites with a mission to make homes and buildings become smart, safe, and advanced as the new standard, announced today that it will host a Corporate Update call and present second quarter 2024 financial results. The conference call will be held on Monday, August 12, 2024 at 4:30 p.m. Eastern time. SKYX Participating Members Will Include: Rani Kohen, Founder and Executive Chairman Steve Schmidt, SKYX...

Continue reading

Quisitive Sets Second Quarter 2024 Earnings Call for Tuesday, August 20, 2024 at 5:00 p.m. ET

TORONTO, Aug. 07, 2024 (GLOBE NEWSWIRE) — Quisitive Technology Solutions, Inc. (“Quisitive” or the “Company”) (TSXV: QUIS, OTCQX: QUISF), a premier Microsoft Cloud and AI solutions provider, will hold a conference call on Tuesday, August 20th at 5:00 p.m. Eastern time (2:00 p.m. Pacific time) to discuss its financial results for the second quarter ended June 30, 2024. Financial results will be issued in a press release prior to the call. Quisitive management will host the earnings call, followed by a question and answer period. Date: Tuesday, August 20, 2024Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time) Webcast Link: HereToll Free dial-in: 1-877-704-4453International dial-in: 1-201-389-0920 Please call the conference telephone number 10 minutes prior to the start time. An operator will register your name and organization....

Continue reading

Clene Reports Second Quarter 2024 Financial Results and Recent Operating Highlights

Survival analyses with CNM-Au8® 30 mg treatment compared to matched PRO-ACT controls demonstrated improved survival up to 3.5 years post-baseline CNM-Au8 treated participants in the HEALEY ALS Platform Trial with substantial neurofilament light (NfL) declines (CNM-Au8 NfL Responders) demonstrated significant clinical improvements in survival, functional status (slowed ALSFRS-R decline), and combined function and survival (CAFS scores) compared to NfL non-responders CNM-Au8 demonstrated neuroprotective effects in an in vitro model of Rett Syndrome, a rare pediatric neurodevelopmental disease Enrolled first ALS patient in NIH-funded Expanded Access Program (EAP) in June Regained compliance with Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq Submitted briefing book to the U.S. Food and Drug Administration (FDA) in advance...

Continue reading

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update

CONCORD, NC, Aug. 07, 2024 (GLOBE NEWSWIRE) — Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain Corporate Highlights and preliminary, unaudited management-prepared financial results for the quarter ended June 30, 2024. These results are based on the most current information available to management, are unaudited and are subject to change upon the completion of the Company’s 2024 year-end financial reporting processes, reviews and audit.  Any resulting adjustments could result in changes to the numbers reported, including material changes. Recent Corporate Highlights Research and Development Twelve (12) research and development (R&D) projects signed with both large and early-stage...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.